Source comparison
BPC-157 TB-500 Stack Gut Healing Protocol: Research Comparison
The following table compares key parameters across research protocols using the BPC-157 TB-500 stack for gut healing applications in 2026: Typical Daily Dose 250–500 mcg subcutaneous 250–500 mcg each peptide subcutaneous Stacking allows lower individual doses
This comparison does not assign a generated winner or score.
- The following table compares key parameters across research protocols using the BPC-157 TB-500 stack for gut healing applications in 2026:
- Typical Daily Dose
- 250–500 mcg subcutaneous
- 250–500 mcg each peptide subcutaneous
- Stacking allows lower individual doses while maintaining efficacy through complementary pathways
- Primary Mechanism
- Angiogenesis, VEGF upregulation, collagen deposition
- Actin binding, cytoskeletal stabilization, cytokine modulation
- Dual mechanism. Structural repair + inflammation control
- BPC-157 rebuilds tissue; TB-500 creates environment for repair to occur
- Observed Healing Timeline
- 3–6 weeks for mucosal integrity restoration
- 2–4 weeks for inflammation reduction, slower structural repair
- 2–4 weeks for both inflammatory and structural endpoints
- Stacking accelerates timeline by addressing both bottlenecks simultaneously
- Administration Route
- Subcutaneous or oral (oral shows systemic effects despite peptide structure)
- Subcutaneous only. Oral bioavailability not established
- Subcutaneous for both peptides
- Subcutaneous ensures consistent plasma levels and systemic distribution
- Protocol Duration
- 4–8 weeks typical, 12 weeks for chronic conditions
- 4–8 weeks typical
- 4–8 weeks typical, with 2-week taper optional
- Most studies show plateau in benefits after 6–8 weeks; extended protocols don't yield proportional gains
- Evidence Base
- 40+ preclinical studies, human case reports, no Phase III trials
- 15+ preclinical studies, primarily wound healing and cardiac research
- 8+ preclinical studies on combined use, growing clinical interest
- BPC-157 has broader gut-specific research; TB-500 evidence is extrapolated from other tissue types